November 2016 – The CenterWatch Monthly : PDF
Sites rate their relationships with IRBs
Institutional review boards (IRBs) received generally positive ratings for their relationships with investigative sites, according to a first-of-its-kind survey conducted by CenterWatch, yet the survey also identified key opportunities for improvement. In addition, nearly half of respondents polled consider the level of IRB oversight excessive.
eConsent adoption advancing and fluid
Electronic informed consent, known as eConsent, is designed to relay study information to patients on a computer or portable device rather than paper. For many reasons, its adoption has been slow, but it continues to evolve.
Also in this issue:
- Pharma and CROs turn to risk-sharing to improve trial performance
- Engaging patients for a more successful clinical trial
- Regulatory Update
- Month in Review
- FDA Actions
- Study Lead Opportunities
- New Drugs in the Pipeline